Dynamic Practice Guidelines For Emergency General Surgery
Dynamic Practice Guidelines For Emergency General Surgery
Dynamic Practice Guidelines For Emergency General Surgery
Hemodynamic instability?
No Yes
Upper GI Endoscopy
1. Resuscitate
within 24 hours
2. Initiate Pharmacotherapy
3. Arrange for Emergent Upper
Source identified? GI endoscopy
4. Surgical and interventional
radiology consultation if upper
No Yes
endoscopy unsuccessful
Colonoscopy to Specific
assess for Lower Treatment based Source identified?
GI Bleeding on etiology
No Yes
Source identified?
Colonoscopy to Specific
No Yes assess for Lower Treatment based
GI Bleeding on etiology
Evaluate for Small
Bowel Bleed
UPPER GI HEMORRHAGE Return to CPG
Overview:
• Defined as bleeding from a source proximal to the ligament of Treitz
• Most common cause: Peptic ulcer disease (H. pylori ± NSAID related)
• Other causes include:
o Esophagogastric varices
o Arteriovenous malformation
o Tumor
o Esophageal (Mallory-Weiss) tear
o Vascular enteric fistula (uncommon but important to consider)
• Spectrum from slow intermittent bleed to brisk life threatening
hemorrhage
• General surgeons tend to manage the more life threatening bleeds
UPPER GI HEMORRHAGE Return to CPG
Risk Assessment:
• Risk assessment/scoring tools can be used to predict re-bleed rate and
mortality (more useful for hemodynamically stable patients
• Glasgow-Blatchford, Rockall and Addenbrooke scores incorporate
biochemistry, patient co-morbidities and endoscopic findings
o Helpful in determining who needs endoscopy or admission
• Essentially, the following are associated with increased risk of re-
bleeding and mortality:
o Tachycardia (heart rate >100bpm)
o Hypotension (blood pressure <100mmHg)
o Age >60
o Significant co-morbidities
o Active bleeding/visible vessel on endoscopy
Resuscitation
• Early consultation with intensive care is prudent
• Hemodynamically unstable patients should be resuscitated in a
monitored setting
• Airway often needs to be definitively controlled
• Transfuse blood, platelets and clotting factors as per local massive
transfusion protocols. A level one infuser can be used to warm and
rapidly administer blood products
• Target hemoglobin of 70 – 90g/L*
• Correct all coagulopathies (including low fibrinogen) – should not delay
endoscopy however
• Other: IV erythromycin (prokinetic) and IV proton pump inhibitor for
patients with active nonvariceal upper gastrointestinal hemorrhage
Variceal Bleed
• Prophylactic antibiotics (Ceftriaxone or a Fluoroquinolone) should be
offered to known cirrhotics.
• Somatostatin or analogues are given to cause splanchnic
vasoconstriction.
• Vasopressin is generally not used as a splanchnic vasoconstrictor due to
its significant systemic side effects – synthetic analogue, terlipressin, can
be used as it has longer biologic activity and fewer side effects.
UPPER GI HEMORRHAGE Return to CPG
Endoscopy
• Should be performed immediately after, or even during resuscitation in
any hemodynamically unstable patient with massive upper
gastrointestinal bleeding.
• Otherwise, should be performed within 24 hours of admission for any
acute upper gastrointestinal bleed.
• Endoscopic treatment modalities include injection/spray (adrenaline,
thrombin), thermal (electrocautery) and mechanical (clips, bands).
• Ideally the surgeon will be present during endoscopy if not the primary
operator in order ascertain the etiology and location of the bleed, while
in addition expediting transfer to the operating theatre is case of
endoscopic failure .
Continue to Further Endoscopy
UPPER GI HEMORRHAGE Return to CPG
Endoscopy
• Endoscopic therapy should be offered if actively bleeding vessel, non
bleeding visible vessel and/or adherent clot are seen. Adherent clots
are removed in order to determine and manage the source of bleeding.
• Combination therapy with adrenaline is superior to adrenaline alone for
nonvariceal upper gastrointestinal bleeding.
• Endoscopic variceal ligation is superior to sclerotherapy for variceal
bleeding. May attempt injection of N-butyl-2-cyanoacrylate for gastric
varices.
• Endoscopic variceal ligation in combination with pharmacotherapy is
superior to ligation alone
UPPER GI HEMORRHAGE Return to CPG
Adapted from Moffat B, et al. UGI Hemorrhage in The Surgical Critical Care Handbook (Chap. 28)
Katschinski B, Logan R, Davies J, et al. 1994. Dig Dis Sci
UPPER GI HEMORRHAGE Return to CPG
Endoscopic Findings
Stigmata of recent hemorrhage and average rates (with ranges) of further bleeding,
surgery, and mortality in prospective trials without endoscopic therapy
Further Bleeding Surgery for Bleeding Mortality
Stigmata
(N=2,994) (N=1,499) (N=1,387)
Active Bleeding 55% (17-100%) 35% (20-69%) 11% (0-23%)
Post-Endoscopy Management
Non-Variceal Bleed
• Should be treated with IV PPI bolus (Pantoprazole 80mg) followed by
continuous infusion (8mg/h for 72 hours).
Variceal Bleed
• Should receive octreotide 50ug IV bolus followed by infusion (50ug/h)
for 3 – 5 days.
• Should continue prophylactic antibiotics.
• Balloon tamponade can be used as a temporizing measure
o Tracheal intubation is required.
o Must confirm balloon is in the proper place before inflating in order
to avoid esophageal rupture.
• Consider transjugular intrahepatic portosystemic shunt (TIPS) if bleeding
not controlled endoscopically.
UPPER GI HEMORRHAGE Return to CPG
Cameron JL, Cameron AM. The Management of Duodenal Ulcer. 2008. Current Surgical Therapy
UPPER GI HEMORRHAGE Return to CPG
Figures from Townsend CM, et al. 2007. Sabiston Textbook of Surgery. Fig. 47-16.
UPPER GI HEMORRHAGE Return to CPG
Summary
• Hemodynamically unstable patients have higher likelihood of operative
intervention.
• Management of upper gastrointestinal bleeding requires a dedicated
multidisciplinary approach.
• Vast majority of bleeds can be controlled with endoscopy and surgery
has shifted from “definitive” ulcer surgery to direct control of bleed.
UPPER GI HEMORRHAGE Return to CPG
Additional Resources
International Practice Guidelines
1. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J
Gastroenterol 2012;107:345-60.
2. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of
nonvariceal upper gastrointestinal hemorrhage: European Society of
Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015;47(10):a1-46
3. Barkun AN, Bardou M, Kuipers EJ, et al. International consensus
recommendations on the management of patients with nonvariceal upper
gastrointestinal bleeding. Ann Intern Med 2010;152:101-13.
4. National Institute for Health and Clinical Excellence. Acute upper gastrointestinal
bleeding: management. London: National Clinical Guideline Centre at the Royal
College of Physicians, 2012.
5. Garcia-Tsao G, Sanyal AJ, Grace ND et al. Prevention and management of
gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J
Gastroenterol 2007;102:2086-2102.